FDA grants priority review to Enhertu for high-risk HER2-positive breast cancer
Bristol Myers Squibb reports positive phase 3 results for oral multiple myeloma therapy
AbbVie reports promising early results for novel obesity therapy ABBV-295
Relmada’s NDV-01 shows strong 12-month results in hard-to-treat bladder cancer
FDA nod to Bristol Myers Squibb’s Sotyktu as new oral therapy for psoriatic arthritis
Avio Smart teams up with Huwel Lifesciences to roll out next-gen molecular diagnostics in India
Mumbai doctors perform India’s first robotic surgery to fix rare uterine defect in 23 year old
Lilly expands affordable access to diabetes & obesity medicines under new medicare programme
Lonza expands manufacturing pact with Genetix to meet rising demand for gene therapy ZYNTEGLO
Neuland to launch commercial peptide facility in Hyderabad as global capacity tightens
The conditional, time-limited approval comes through a joint effort with RACTHERA, a joint venture in which Sumitomo Chemical holds a 66.6% stake and Sumitomo Pharma holds 33.4%
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
.jpg?v=1773169808)
